483 Abraxis Bioscience Apr 2022

483 Abraxis Bioscience Apr 2022

$119 - Not in Stock

FDA investigators audited the Abraxis Bioscience - Phoenix, AZ, United States facility and issued inspectional observations (via FDA 483) on 06 Apr 2022.

Product details

  • Category: Human Drugs
  • Inspection end: 06 Apr 2022
  • Location: Phoenix, United States
  • FEI: 3006441852

Pre-Order Not Available